Core Viewpoint - Huaxia Eye Hospital's stock price has declined significantly since its IPO, currently trading at 20.72 yuan, representing a drop of 2.95% and indicating a state of underperformance since its initial offering price of 50.88 yuan [1] Group 1: IPO and Financial Performance - Huaxia Eye Hospital was listed on the Shenzhen Stock Exchange's ChiNext board on November 7, 2022, with an initial offering price of 50.88 yuan per share [1] - The total funds raised from the IPO amounted to 305.28 million yuan, with a net amount of 276.85 million yuan after deducting issuance costs [1] - The final amount raised exceeded the original plan by 198.99 million yuan, which was initially set at 77.85 million yuan for various projects [1] Group 2: Use of Proceeds - The funds raised are intended for several projects, including the Tianjin Huaxia Eye Hospital project, regional vision center construction, upgrading existing medical service capabilities, information management system development, and supplementing operational funds [1] Group 3: Dividend Distribution - On July 4, 2023, Huaxia Eye Hospital announced a cash dividend of 2.8 yuan per 10 shares, totaling 15.68 million yuan, based on a total share capital of 56 million shares as of December 31, 2022 [2] - Additionally, the company will increase its share capital by 5 shares for every 10 shares held, raising the total share capital from 56 million to 84 million shares [2]
破发股华厦眼科跌2.95% 2022年上市超募19.9亿元